Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Bazedoxifene acetate

EU orphan designation number: EU/3/14/1367   
Active ingredient: Bazedoxifene acetate
Indication: Treatment of hereditary haemorrhagic telangiectasia
Sponsor: Consejo Superior de Investigaciones Cientificas (CSIC)
C/ Serrano 142, 28006 Madrid, España

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
21/11/2014 Orphan designation EMA/OD/144/14 (2014)8862 of 19/11/2014